EEF2 and cancer: Notably, recent findings suggest that the phosphorylation status of eEF2 differs between in vivo and in vitro cancer cells exposed to compound treatments; thus, elucidating the underlying mechanisms and identifying sensitive inhibitors is crucial for advancing both basic and clinical research.